Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 47 (11%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 375 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-02-26 | 2024-05-02 | 220633 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-25 | 2024-04-23 | 223214 |
| CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-20 | 2020-10-30 | 126740 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-15 | 2019-02-13 | 72253 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-13 | 2019-11-14 | 93859 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2023-10-01 | 200434 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-04-22 | 2024-05-17 | 225878 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-12-20 | 2020-02-06 | 101823 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-03-24 | 2020-04-21 | 109287 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-21 | 2019-02-13 | 67303 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-27 | 2019-07-06 | 87571 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-18 | 2023-12-01 | 198918 |
| PRAVASTATIN | 20MG | TABLET | Resolved | 2019-11-21 | 2020-02-04 | 99491 |
| PRAVASTATIN | 40MG | TABLET | Resolved | 2019-10-21 | 2020-02-19 | 96871 |
| TOPIRAMATE | 200MG | TABLET | Resolved | 2018-08-14 | 2018-08-28 | 58056 |
| RISPERIDONE | 0.25MG | TABLET | Resolved | 2024-03-25 | 2024-05-17 | 223270 |
| LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-02-19 | 2020-12-11 | 76304 |
| LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-11-21 | 2020-12-11 | 67307 |
| LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-18 | 2023-09-19 | 198933 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2018-03-13 | 2018-05-03 | 42756 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |